Latest filing published 13 May 2024 for Infant Bacterial Therapeutics IBT, €7,983.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Margareta Hagman: trading record in brief
Margareta Hagman appears in our data through filings on Infant Bacterial Therapeutics IBT shares, published by Finansinspektionen. In total, 2 filings cover trades dated from 31 January 2018 to 13 May 2024.
Purchases make up the whole of the open-market record (2 purchases, €22k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2024, the count stands at 1 purchase and no sales.
On 13 May 2024 came the latest disclosure, an open-market purchase for €7,983 in Infant Bacterial Therapeutics IBT. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Margareta Hagman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ SEK 93.409835.9% of flowAktieISIN SE0010713958FI:csv-564c0af7d5013dde9556Canonical exit: 11 Aug 2024 (T+90)
- 1,470 shares@ SEK 95.00100.0% of flowISIN SE0010713958FI:csv-0f403a6873d713b01757Canonical exit: 1 May 2018 (T+90)
2 of 2 declarations